We are live on ! Find out more
RFC

Russell Frank Company Portfolio holdings

AUM $56.9B
1-Year Est. Return 2.13%
This Fund
S&P 500
This Quarter Est. Return
+7.02%
1 Year Est. Return
+2.13%
3 Year Est. Return
+42.95%
5 Year Est. Return
10 Year Est. Return
AUM
$56.9B
AUM Growth
+$2.28B
Cap. Flow
-$893M
Cap. Flow %
-1.57%
Top 10 Hldgs %
9.98%
Holding
3,594
New
174
Increased
1,805
Reduced
1,400
Closed
130

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$94.4M
2
ORCL icon
Oracle
ORCL
+$72.1M
3
TWX
Time Warner Inc
TWX
+$57.8M
4
GM icon
General Motors
GM
+$51.1M
5
PVH icon
PVH
PVH
+$44M

Sector Composition

Rank Sector Weight
1 Financials 16.55%
2 Technology 12.88%
3 Industrials 11.19%
4 Healthcare 11.1%
5 Consumer Discretionary 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCLR
3251
DELISTED
Oclaro Inc.
OCLR
$16K ﹤0.01%
8,899
-467
-5% -$578
GUID
3252
DELISTED
Guidance Software, Inc.
GUID
$16K ﹤0.01%
1,803
-12
-0.7% -$105
CIFC
3253
DELISTED
CIFC LLC Common Shares
CIFC
$16K ﹤0.01%
1,978
+1,935
+4,500% +$14.6K
CVLG icon
3254
Covenant Logistics
CVLG
$872M
$15K ﹤0.01%
4,642
INVE icon
3255
Identive
INVE
$61.9M
$15K ﹤0.01%
2,180
SUMR
3256
DELISTED
Summer Infant, Inc.
SUMR
$15K ﹤0.01%
592
-3,178
-84% -$93.5K
DM
3257
DELISTED
DOLAN COMPANY COMMON STOCK
DM
$15K ﹤0.01%
6,471
-181
-3% -$405
SCTY
3258
DELISTED
SolarCity Corporation
SCTY
$15K ﹤0.01%
+440
New +$16.5K
ABCD
3259
DELISTED
Cambium Learning Group, Inc.
ABCD
$14K ﹤0.01%
9,330
CASC
3260
DELISTED
Cascadian Therapeutics, Inc.
CASC
$14K ﹤0.01%
1,117
-59
-5% -$621
PTX
3261
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$14K ﹤0.01%
506
+500
+8,333% +$16.1K
STRI
3262
DELISTED
STR HLDGS INC COM STK NEW (DE)
STRI
$14K ﹤0.01%
2,166
-63
-3% -$407
VIAS
3263
DELISTED
VIASYSTEMS GROUP INC COM STK (DE)
VIAS
$14K ﹤0.01%
978
+949
+3,272% +$13.4K
CWTR
3264
DELISTED
COLDWATER CREEK INC COM STK NEW (DE)
CWTR
$14K ﹤0.01%
8,029
CPSS icon
3265
Consumer Portfolio Services
CPSS
$206M
$13K ﹤0.01%
+2,161
New +$13.7K
ORRF icon
3266
Orrstown Financial Services
ORRF
$838M
$13K ﹤0.01%
744
NYMX
3267
DELISTED
Nymox Pharmaceutical Corp
NYMX
$13K ﹤0.01%
1,990
MEA
3268
DELISTED
METALICO INC
MEA
$13K ﹤0.01%
9,560
-227
-2% -$314
CYTK icon
3269
Cytokinetics
CYTK
$10.4B
$12K ﹤0.01%
+1,545
New +$16.6K
TAM
3270
DELISTED
TAMINCO CORP COM
TAM
$12K ﹤0.01%
+590
New +$12.2K
DOC
3271
DELISTED
PHYSICIANS REALTY TRUST
DOC
$12K ﹤0.01%
+990
New +$11.6K
TRC icon
3272
Tejon Ranch
TRC
$451M
$11K ﹤0.01%
367
+279
+317% +$8.48K
VGZ icon
3273
Vista Gold
VGZ
$308M
$11K ﹤0.01%
24,030
-359
-1% -$295
XOMA
3274
DELISTED
Xoma
XOMA
$11K ﹤0.01%
125
-7,777
-98% -$707K
BPY
3275
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$11K ﹤0.01%
588

Similar funds

Russell Frank Company's Q3 2013 Portfolio in Review

As of Q3 2013, Russell Frank Company held 3,594 positions worth $56.9B, up 4.2% from $54.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Russell Frank Company's Q3 2013 filing shows 174 new, 1,805 increased, 1,400 reduced and 130 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 1,013,242 shares worth $33.9M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $134M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.

  • Russell Frank Company's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 1,013,242 shares worth $33.9M.
  • Russell Frank Company added most to Boeing in Q3 2013, an estimated $94.4M increase.
  • Russell Frank Company's biggest Q3 2013 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $134M.
  • Russell Frank Company fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q3 2013, selling an estimated $125M.
  • Russell Frank Company's ten largest holdings make up 10% of its $56.9B portfolio in Q3 2013.
  • Russell Frank Company opened 174 new positions and closed 130 in Q3 2013.
  • Russell Frank Company's portfolio value rose 4.2% quarter-over-quarter to $56.9B.

Based on Russell Frank Company's 13F filing for Q3 2013, filed 29 Oct 2013.